TNXP — Tonix Pharmaceuticals Holding Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for Tonix Pharmaceuticals Holding, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	11.2	77.1	179	120	24.9
Total Inventory
Prepaid Expenses
Total Current Assets	13.9	88	189	131	47.8
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.39	9.83	51.5	94.5	94.9
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	14.6	98.2	241	226	154
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	5.13	9.82	21.7	18.2	18.9
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	5.14	10.5	22.2	18.5	48.9
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	9.42	87.6	219	207	106
Total Liabilities & Shareholders' Equity	14.6	98.2	241	226	154
Total Common Shares Outstanding